-
Searching For A Treatment: NASH Investigational Drugs With Catalysts This Year
Friday, January 18, 2019 - 10:15am | 1122Non-alcoholic fatty liver disease, or NAFLD, is a disorder resulting from accumulation of fat in the liver of people who do not consume alcohol. NAFLD is a less serious condition, although non-alcoholic steatohepatitis, or NASH — a subset of NAFLD — is life-threatening, given its...
-
New Class of Migraine Drug Creates Four-Way Pharma Development Race
Thursday, September 6, 2018 - 3:58pm | 1272Migraines — a neurological condition often characterized by intense, debilitating headaches — can last anywhere from four to 72 hours, affecting a patient's quality of life. Until recently, there was no specific treatment for migraine, although symptom-alleviating options...